{"protocolSection": {"identificationModule": {"nctId": "NCT01967173", "orgStudyIdInfo": {"id": "AsthmaNet 006"}, "secondaryIdInfos": [{"id": "1U10HL098115", "type": "NIH", "link": "https://reporter.nih.gov/quickSearch/1U10HL098115"}], "organization": {"fullName": "Milton S. Hershey Medical Center", "class": "OTHER"}, "briefTitle": "Best African American Response to Asthma Drugs", "officialTitle": "Best African American Response to Asthma Drugs", "acronym": "BARD"}, "statusModule": {"statusVerifiedDate": "2018-10", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2014-02"}, "primaryCompletionDateStruct": {"date": "2017-07-01", "type": "ACTUAL"}, "completionDateStruct": {"date": "2017-07-01", "type": "ACTUAL"}, "studyFirstSubmitDate": "2013-10-11", "studyFirstSubmitQcDate": "2013-10-17", "studyFirstPostDateStruct": {"date": "2013-10-22", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2018-09-10", "resultsFirstSubmitQcDate": "2018-10-15", "resultsFirstPostDateStruct": {"date": "2018-11-15", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2018-10-15", "lastUpdatePostDateStruct": {"date": "2018-11-15", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "PRINCIPAL_INVESTIGATOR", "investigatorFullName": "dave mauger", "investigatorTitle": "Principal Investigator, AsthmaNet Data Coordinating Center", "investigatorAffiliation": "Milton S. Hershey Medical Center"}, "leadSponsor": {"name": "Milton S. Hershey Medical Center", "class": "OTHER"}, "collaborators": [{"name": "National Heart, Lung, and Blood Institute (NHLBI)", "class": "NIH"}]}, "oversightModule": {"oversightHasDmc": true}, "descriptionModule": {"briefSummary": "The purpose of this study is to find the best asthma treatment to add for Blacks who have asthma that is not well controlled on a low dose of inhaled steroid. This study will also try to find out if Black adults and children differ in how they respond to the medications used in this study.", "detailedDescription": "BARD is a 66 week prospective, randomized, double-blind, crossover trial in Blacks (individuals who self-report Black ancestry) who have inadequately controlled asthma while taking low-dose inhaled corticosteroids (ICS). BARD will examine the efficacy of increasing the dose of ICS with or without the addition of a long-acting beta agonist (LABA) to determine whether individual patients respond better to one treatment than another and, if so, whether the responses are different for children and adults or if they are related to genetic ancestry."}, "conditionsModule": {"conditions": ["Asthma"], "keywords": ["Asthma", "Fluticasone", "Salmeterol"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE3"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "CROSSOVER", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "QUADRUPLE", "whoMasked": ["PARTICIPANT", "CARE_PROVIDER", "INVESTIGATOR", "OUTCOMES_ASSESSOR"]}}, "enrollmentInfo": {"count": 574, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Crossover sequence 1", "type": "EXPERIMENTAL", "description": "Flovent Diskus\u00ae 250 mcg,followed by Advair Diskus\u00ae 250/50 mcg, followed by Flovent Diskus\u00ae 100 mcg, followed by Advair Diskus\u00ae 100/50 mcg", "interventionNames": ["Drug: Flovent Diskus\u00ae 100 mcg", "Drug: Flovent Diskus\u00ae 250 mcg", "Drug: Advair Diskus\u00ae 100/50 mcg", "Drug: Advair Diskus\u00ae 250/50 mcg"]}, {"label": "Crossover sequence 2", "type": "EXPERIMENTAL", "description": "Advair Diskus\u00ae 250/50 mcg, followed by Advair Diskus\u00ae 100/50 mcg, followed by Flovent Diskus\u00ae 250 mcg, followed by Flovent Diskus\u00ae 100 mcg", "interventionNames": ["Drug: Flovent Diskus\u00ae 100 mcg", "Drug: Flovent Diskus\u00ae 250 mcg", "Drug: Advair Diskus\u00ae 100/50 mcg", "Drug: Advair Diskus\u00ae 250/50 mcg"]}, {"label": "Crossover sequence 3", "type": "EXPERIMENTAL", "description": "Flovent Diskus\u00ae 100 mcg, followed by Flovent Diskus\u00ae 250 mcg, followed by Advair Diskus\u00ae 100/50 mcg, followed by Advair Diskus\u00ae 250/50 mcg", "interventionNames": ["Drug: Flovent Diskus\u00ae 100 mcg", "Drug: Flovent Diskus\u00ae 250 mcg", "Drug: Advair Diskus\u00ae 100/50 mcg", "Drug: Advair Diskus\u00ae 250/50 mcg"]}, {"label": "Crossover sequence 4", "type": "EXPERIMENTAL", "description": "Advair Diskus\u00ae 100/50 mcg, followed by Flovent Diskus\u00ae 100 mcg, followed by Advair Diskus\u00ae 250/50 mcg, followed by Flovent Diskus\u00ae 250 mcg", "interventionNames": ["Drug: Flovent Diskus\u00ae 100 mcg", "Drug: Flovent Diskus\u00ae 250 mcg", "Drug: Advair Diskus\u00ae 100/50 mcg", "Drug: Advair Diskus\u00ae 250/50 mcg"]}, {"label": "Crossover sequence 5", "type": "EXPERIMENTAL", "description": "Flovent Diskus\u00ae 500 mcg, followed by Advair Diskus\u00ae 250/50 mcg, followed by Flovent Diskus\u00ae 250 mcg, followed by Advair Diskus\u00ae 100/50 mcg", "interventionNames": ["Drug: Flovent Diskus\u00ae 250 mcg", "Drug: Flovent Diskus\u00ae 500 mcg", "Drug: Advair Diskus\u00ae 100/50 mcg", "Drug: Advair Diskus\u00ae 250/50 mcg"]}, {"label": "Crossover sequence 6", "type": "EXPERIMENTAL", "description": "Advair Diskus\u00ae 250/50 mcg, followed by Advair Diskus\u00ae 100/50 mcg, followed by Flovent Diskus\u00ae 500 mcg, followed by Flovent Diskus\u00ae 250 mcg", "interventionNames": ["Drug: Flovent Diskus\u00ae 250 mcg", "Drug: Flovent Diskus\u00ae 500 mcg", "Drug: Advair Diskus\u00ae 100/50 mcg", "Drug: Advair Diskus\u00ae 250/50 mcg"]}, {"label": "Crossover sequence 7", "type": "EXPERIMENTAL", "description": "Flovent Diskus\u00ae 250 mcg, followed by Flovent Diskus\u00ae 500 mcg, followed by Advair Diskus\u00ae 100/50 mcg, followed by Advair Diskus\u00ae 250/50 mcg", "interventionNames": ["Drug: Flovent Diskus\u00ae 250 mcg", "Drug: Flovent Diskus\u00ae 500 mcg", "Drug: Advair Diskus\u00ae 100/50 mcg", "Drug: Advair Diskus\u00ae 250/50 mcg"]}, {"label": "Crossover sequence 8", "type": "EXPERIMENTAL", "description": "Advair Diskus\u00ae 100/50 mcg, followed by Flovent Diskus\u00ae 250 mcg, followed by Advair Diskus\u00ae 250/50 mcg, followed by Flovent Diskus\u00ae 500 mcg", "interventionNames": ["Drug: Flovent Diskus\u00ae 250 mcg", "Drug: Flovent Diskus\u00ae 500 mcg", "Drug: Advair Diskus\u00ae 100/50 mcg", "Drug: Advair Diskus\u00ae 250/50 mcg"]}], "interventions": [{"type": "DRUG", "name": "Flovent Diskus\u00ae 100 mcg", "description": "Flovent is an ICS", "armGroupLabels": ["Crossover sequence 1", "Crossover sequence 2", "Crossover sequence 3", "Crossover sequence 4"]}, {"type": "DRUG", "name": "Flovent Diskus\u00ae 250 mcg", "description": "Flovent is an ICS", "armGroupLabels": ["Crossover sequence 1", "Crossover sequence 2", "Crossover sequence 3", "Crossover sequence 4", "Crossover sequence 5", "Crossover sequence 6", "Crossover sequence 7", "Crossover sequence 8"]}, {"type": "DRUG", "name": "Flovent Diskus\u00ae 500 mcg", "description": "Flovent is an ICS", "armGroupLabels": ["Crossover sequence 5", "Crossover sequence 6", "Crossover sequence 7", "Crossover sequence 8"]}, {"type": "DRUG", "name": "Advair Diskus\u00ae 100/50 mcg", "description": "Advair is an ICS/LABA combination", "armGroupLabels": ["Crossover sequence 1", "Crossover sequence 2", "Crossover sequence 3", "Crossover sequence 4", "Crossover sequence 5", "Crossover sequence 6", "Crossover sequence 7", "Crossover sequence 8"]}, {"type": "DRUG", "name": "Advair Diskus\u00ae 250/50 mcg", "description": "Advair is an ICS/LABA combination", "armGroupLabels": ["Crossover sequence 1", "Crossover sequence 2", "Crossover sequence 3", "Crossover sequence 4", "Crossover sequence 5", "Crossover sequence 6", "Crossover sequence 7", "Crossover sequence 8"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "The Primary Outcome is a Composite Measure That Uses Exacerbations, Asthma Control Days During the Last 12 of 14 Weeks of a Treatment Regimen, and Percent Predicted FEV1 at the End of a Treatment Regimen.", "description": "This composite outcome uses a hierarchical method to ascertain differences in asthma control. For each participant, treatments are first compared to see if they differ in terms of exacerbations. If one treatment results in fewer exacerbations than another, it is deemed the superior treatment and no further comparisons are made. If treatment superiority cannot be assigned by exacerbations, then they are compared by asthma control days (ACDs). If one treatment yields at least 31 annualized ACDs more than another, it is deemed the superior treatment. If treatment superiority still cannot be assigned by ACDs, then they are compared by percent predicted FEV1 at the end of a treatment period. If one treatment yields at least 5% greater FEV1 than another, it is deemed the superior treatment. If treatment superiority cannot be assigned by exacerbations, ACDs or FEV1, then that participant is classified as having no differential response.", "timeFrame": "The last 12 weeks of each 14-week treatment period"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n1. Individuals who self-report Black ancestry (with at least 1 Black grandparent).\n2. Able to perform reproducible spirometry according to ATS criteria.\n3. Clinical history consistent with asthma.\n4. Baseline FEV1\u226540% of predicted and/or post-bronchodilator FEV1\u226540% of predicted.\n5. Asthma confirmed either by: (1) Beta-agonist reversibility to 4 puffs albuterol \u2265 12% OR (2) PC20FEV1 \u2264 16 mg/ml OR (3) an absolute relative change in %predicted FEV1 of \u2265 12% over two measurements documented by repeat spirogram over the previous year\n6. Either: A) inadequately controlled on low-, medium- or high-dose ICS monotherapy, or low- or medium-dose ICS/LABA, or B) well-controlled on medium- or high-dose ICS monotherapy, or low-, medium- or high-dose ICS/LABA. Inadequate asthma control will be defined as an ACT/c-ACT score \\<20; well-controlled asthma will be defined as an ACT/c-ACT score \u226520.\n7. Stable asthma controller therapy dose (ICS or ICS/LABA) for the 2 weeks prior to enrollment.\n8. Non-smoker (total lifetime smoking history \\< 5 pack-years if \\<18, or \\<10 pack-years if \u226518 years of age; no smoking for at least 1 year).\n9. For participants \u226518 years of age: Ability to provide informed consent. For participants under 18 years of age: Ability to provide verbal or written assent and ability of parent to provide informed consent.\n\nExclusion Criteria:\n\n1. Medical contraindication to LABA or history of adverse reactions to ICS or LABA preparations or any of their ingredients.\n2. Current or prior use of medications known to significantly interact with corticosteroid disposition within the two-week period preceding enrollment.\n3. Unwilling to provide a blood sample for DNA extraction and genetic analysis.\n4. Major medical problems prohibiting study participation, i.e. presence of chronic or active lung disease other than asthma or history of unstable significant medical illness other than asthma, including thyroid disease, diabetes mellitus, Cushing's disease, Addison's disease, hepatic disease, or concurrent medical problems that could require oral corticosteroids during the study or that would place the participant at increased risk.\n5. Systemic corticosteroid treatment for any condition within 4 weeks of enrollment or more than five courses of systemic corticosteroids in the past year.\n6. History of a life-threatening asthma exacerbation requiring intubation, mechanical ventilation, or resulting in a hypoxic seizure within the last 2 years.\n7. History of a respiratory tract infection within 4 weeks of enrollment.\n8. If a female of child-bearing potential, failure to practice abstinence or use an acceptable birth control method.\n9. Pregnancy or lactation or planning to get pregnant during the course of the trial.\n10. Receiving hyposensitization therapy other than an established maintenance regimen defined as a continuous regimen for \u2265 3 months prior to enrollment.\n11. Participation in an intervention trial or use of investigative drugs in the past 30 days or plans to enroll in such a trial during the study.", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "5 Years", "stdAges": ["CHILD", "ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "William Busse, MD", "affiliation": "University of Wisconsin, Madison", "role": "STUDY_CHAIR"}], "locations": [{"facility": "University of Arizona College of Medicine", "city": "Tucson", "state": "Arizona", "zip": "85724", "country": "United States", "geoPoint": {"lat": 32.22174, "lon": -110.92648}}, {"facility": "Children's Hospital & Research Center Oakland", "city": "Oakland", "state": "California", "zip": "94609", "country": "United States", "geoPoint": {"lat": 37.80437, "lon": -122.2708}}, {"facility": "UCSF Benioff Children's Hospital", "city": "San Francisco", "state": "California", "zip": "94143", "country": "United States", "geoPoint": {"lat": 37.77493, "lon": -122.41942}}, {"facility": "University of California - San Francisco", "city": "San Francisco", "state": "California", "zip": "94143", "country": "United States", "geoPoint": {"lat": 37.77493, "lon": -122.41942}}, {"facility": "National Jewish Health", "city": "Denver", "state": "Colorado", "zip": "80206", "country": "United States", "geoPoint": {"lat": 39.73915, "lon": -104.9847}}, {"facility": "Nemours Children's Clinic", "city": "Jacksonville", "state": "Florida", "zip": "32207", "country": "United States", "geoPoint": {"lat": 30.33218, "lon": -81.65565}}, {"facility": "Nemours Children's Clinic", "city": "Orlando", "state": "Florida", "zip": "32827", "country": "United States", "geoPoint": {"lat": 28.53834, "lon": -81.37924}}, {"facility": "Emory University", "city": "Atlanta", "state": "Georgia", "zip": "30322", "country": "United States", "geoPoint": {"lat": 33.749, "lon": -84.38798}}, {"facility": "Northwestern Memorial Hospital", "city": "Chicago", "state": "Illinois", "zip": "60611", "country": "United States", "geoPoint": {"lat": 41.85003, "lon": -87.65005}}, {"facility": "Rush University Medical Center", "city": "Chicago", "state": "Illinois", "zip": "60612", "country": "United States", "geoPoint": {"lat": 41.85003, "lon": -87.65005}}, {"facility": "University of Illinois at Chicago", "city": "Chicago", "state": "Illinois", "zip": "60612", "country": "United States", "geoPoint": {"lat": 41.85003, "lon": -87.65005}}, {"facility": "Ann and Robert H. Lurie Children's Hospital", "city": "Chicago", "state": "Illinois", "zip": "60614", "country": "United States", "geoPoint": {"lat": 41.85003, "lon": -87.65005}}, {"facility": "University of Chicago", "city": "Chicago", "state": "Illinois", "zip": "60637", "country": "United States", "geoPoint": {"lat": 41.85003, "lon": -87.65005}}, {"facility": "Brigham & Women's Hospital", "city": "Boston", "state": "Massachusetts", "zip": "02115", "country": "United States", "geoPoint": {"lat": 42.35843, "lon": -71.05977}}, {"facility": "Children's Hospital Boston", "city": "Boston", "state": "Massachusetts", "zip": "02115", "country": "United States", "geoPoint": {"lat": 42.35843, "lon": -71.05977}}, {"facility": "St. Louis Children's Hospital", "city": "Saint Louis", "state": "Missouri", "zip": "63110", "country": "United States", "geoPoint": {"lat": 38.62727, "lon": -90.19789}}, {"facility": "Washington University", "city": "Saint Louis", "state": "Missouri", "zip": "63110", "country": "United States", "geoPoint": {"lat": 38.62727, "lon": -90.19789}}, {"facility": "University of New Mexico", "city": "Albuquerque", "state": "New Mexico", "zip": "87131", "country": "United States", "geoPoint": {"lat": 35.08449, "lon": -106.65114}}, {"facility": "Columbia University Medical Center", "city": "New York", "state": "New York", "zip": "10032", "country": "United States", "geoPoint": {"lat": 40.71427, "lon": -74.00597}}, {"facility": "Duke University School of Medicine", "city": "Durham", "state": "North Carolina", "zip": "27110", "country": "United States", "geoPoint": {"lat": 35.99403, "lon": -78.89862}}, {"facility": "North Carolina Clinical Research", "city": "Raleigh", "state": "North Carolina", "zip": "27607", "country": "United States", "geoPoint": {"lat": 35.7721, "lon": -78.63861}}, {"facility": "Wake Forest University Health Sciences", "city": "Winston-Salem", "state": "North Carolina", "zip": "27157", "country": "United States", "geoPoint": {"lat": 36.09986, "lon": -80.24422}}, {"facility": "Rainbow Babies and Children's Hospital, Case Western Reserve University", "city": "Cleveland", "state": "Ohio", "zip": "44106", "country": "United States", "geoPoint": {"lat": 41.4995, "lon": -81.69541}}, {"facility": "Allegheny General Hospital", "city": "Pittsburgh", "state": "Pennsylvania", "zip": "15212", "country": "United States", "geoPoint": {"lat": 40.44062, "lon": -79.99589}}, {"facility": "University of Pittsburgh", "city": "Pittsburgh", "state": "Pennsylvania", "zip": "15213", "country": "United States", "geoPoint": {"lat": 40.44062, "lon": -79.99589}}, {"facility": "Children's Hospital of Pittsburgh of UPMC", "city": "Pittsburgh", "state": "Pennsylvania", "zip": "15224", "country": "United States", "geoPoint": {"lat": 40.44062, "lon": -79.99589}}, {"facility": "University of Wisconsin-Madison", "city": "Madison", "state": "Wisconsin", "zip": "53792", "country": "United States", "geoPoint": {"lat": 43.07305, "lon": -89.40123}}, {"facility": "Center for Urban Population Health", "city": "Milwaukee", "state": "Wisconsin", "zip": "53223", "country": "United States", "geoPoint": {"lat": 43.0389, "lon": -87.90647}}]}, "referencesModule": {"references": [{"pmid": "31553835", "type": "DERIVED", "citation": "Wechsler ME, Szefler SJ, Ortega VE, Pongracic JA, Chinchilli V, Lima JJ, Krishnan JA, Kunselman SJ, Mauger D, Bleecker ER, Bacharier LB, Beigelman A, Benson M, Blake KV, Cabana MD, Cardet JC, Castro M, Chmiel JF, Covar R, Denlinger L, DiMango E, Fitzpatrick AM, Gentile D, Grossman N, Holguin F, Jackson DJ, Kumar H, Kraft M, LaForce CF, Lang J, Lazarus SC, Lemanske RF Jr, Long D, Lugogo N, Martinez F, Meyers DA, Moore WC, Moy J, Naureckas E, Olin JT, Peters SP, Phipatanakul W, Que L, Raissy H, Robison RG, Ross K, Sheehan W, Smith LJ, Solway J, Sorkness CA, Sullivan-Vedder L, Wenzel S, White S, Israel E; NHLBI AsthmaNet. Step-Up Therapy in Black Children and Adults with Poorly Controlled Asthma. N Engl J Med. 2019 Sep 26;381(13):1227-1239. doi: 10.1056/NEJMoa1905560."}], "seeAlsoLinks": [{"label": "AsthmaNet", "url": "http://asthmanetresearch.org/"}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "Crossover Sequence 1", "description": "Flovent Diskus\u00ae 250 mcg,followed by Advair Diskus\u00ae 250/50 mcg, followed by Flovent Diskus\u00ae 100 mcg, followed by Advair Diskus\u00ae 100/50 mcg\n\nFlovent Diskus\u00ae 100 mcg: Flovent is an ICS\n\nFlovent Diskus\u00ae 250 mcg: Flovent is an ICS\n\nAdvair Diskus\u00ae 100/50 mcg: Advair is an ICS/LABA combination\n\nAdvair Diskus\u00ae 250/50 mcg: Advair is an ICS/LABA combination"}, {"id": "FG001", "title": "Crossover Sequence 2", "description": "Advair Diskus\u00ae 250/50 mcg, followed by Advair Diskus\u00ae 100/50 mcg, followed by Flovent Diskus\u00ae 250 mcg, followed by Flovent Diskus\u00ae 100 mcg\n\nFlovent Diskus\u00ae 100 mcg: Flovent is an ICS\n\nFlovent Diskus\u00ae 250 mcg: Flovent is an ICS\n\nAdvair Diskus\u00ae 100/50 mcg: Advair is an ICS/LABA combination\n\nAdvair Diskus\u00ae 250/50 mcg: Advair is an ICS/LABA combination"}, {"id": "FG002", "title": "Crossover Sequence 3", "description": "Flovent Diskus\u00ae 100 mcg, followed by Flovent Diskus\u00ae 250 mcg, followed by Advair Diskus\u00ae 100/50 mcg, followed by Advair Diskus\u00ae 250/50 mcg\n\nFlovent Diskus\u00ae 100 mcg: Flovent is an ICS\n\nFlovent Diskus\u00ae 250 mcg: Flovent is an ICS\n\nAdvair Diskus\u00ae 100/50 mcg: Advair is an ICS/LABA combination\n\nAdvair Diskus\u00ae 250/50 mcg: Advair is an ICS/LABA combination"}, {"id": "FG003", "title": "Crossover Sequence 4", "description": "Advair Diskus\u00ae 100/50 mcg, followed by Flovent Diskus\u00ae 100 mcg, followed by Advair Diskus\u00ae 250/50 mcg, followed by Flovent Diskus\u00ae 250 mcg\n\nFlovent Diskus\u00ae 100 mcg: Flovent is an ICS\n\nFlovent Diskus\u00ae 250 mcg: Flovent is an ICS\n\nAdvair Diskus\u00ae 100/50 mcg: Advair is an ICS/LABA combination\n\nAdvair Diskus\u00ae 250/50 mcg: Advair is an ICS/LABA combination"}, {"id": "FG004", "title": "Crossover Sequence 5", "description": "Flovent Diskus\u00ae 500 mcg, followed by Advair Diskus\u00ae 250/50 mcg, followed by Flovent Diskus\u00ae 250 mcg, followed by Advair Diskus\u00ae 100/50 mcg\n\nFlovent Diskus\u00ae 250 mcg: Flovent is an ICS\n\nFlovent Diskus\u00ae 500 mcg: Flovent is an ICS\n\nAdvair Diskus\u00ae 100/50 mcg: Advair is an ICS/LABA combination\n\nAdvair Diskus\u00ae 250/50 mcg: Advair is an ICS/LABA combination"}, {"id": "FG005", "title": "Crossover Sequence 6", "description": "Advair Diskus\u00ae 250/50 mcg, followed by Advair Diskus\u00ae 100/50 mcg, followed by Flovent Diskus\u00ae 500 mcg, followed by Flovent Diskus\u00ae 250 mcg\n\nFlovent Diskus\u00ae 250 mcg: Flovent is an ICS\n\nFlovent Diskus\u00ae 500 mcg: Flovent is an ICS\n\nAdvair Diskus\u00ae 100/50 mcg: Advair is an ICS/LABA combination\n\nAdvair Diskus\u00ae 250/50 mcg: Advair is an ICS/LABA combination"}, {"id": "FG006", "title": "Crossover Sequence 7", "description": "Flovent Diskus\u00ae 250 mcg, followed by Flovent Diskus\u00ae 500 mcg, followed by Advair Diskus\u00ae 100/50 mcg, followed by Advair Diskus\u00ae 250/50 mcg\n\nFlovent Diskus\u00ae 250 mcg: Flovent is an ICS\n\nFlovent Diskus\u00ae 500 mcg: Flovent is an ICS\n\nAdvair Diskus\u00ae 100/50 mcg: Advair is an ICS/LABA combination\n\nAdvair Diskus\u00ae 250/50 mcg: Advair is an ICS/LABA combination"}, {"id": "FG007", "title": "Crossover Sequence 8", "description": "Advair Diskus\u00ae 100/50 mcg, followed by Flovent Diskus\u00ae 250 mcg, followed by Advair Diskus\u00ae 250/50 mcg, followed by Flovent Diskus\u00ae 500 mcg\n\nFlovent Diskus\u00ae 250 mcg: Flovent is an ICS\n\nFlovent Diskus\u00ae 500 mcg: Flovent is an ICS\n\nAdvair Diskus\u00ae 100/50 mcg: Advair is an ICS/LABA combination\n\nAdvair Diskus\u00ae 250/50 mcg: Advair is an ICS/LABA combination"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "69"}, {"groupId": "FG001", "numSubjects": "69"}, {"groupId": "FG002", "numSubjects": "71"}, {"groupId": "FG003", "numSubjects": "71"}, {"groupId": "FG004", "numSubjects": "73"}, {"groupId": "FG005", "numSubjects": "72"}, {"groupId": "FG006", "numSubjects": "75"}, {"groupId": "FG007", "numSubjects": "74"}]}, {"type": "Completed 1st Period", "achievements": [{"groupId": "FG000", "numSubjects": "58"}, {"groupId": "FG001", "numSubjects": "60"}, {"groupId": "FG002", "numSubjects": "67"}, {"groupId": "FG003", "numSubjects": "65"}, {"groupId": "FG004", "numSubjects": "64"}, {"groupId": "FG005", "numSubjects": "62"}, {"groupId": "FG006", "numSubjects": "67"}, {"groupId": "FG007", "numSubjects": "69"}]}, {"type": "Completed 2nd Period", "achievements": [{"groupId": "FG000", "numSubjects": "52"}, {"groupId": "FG001", "numSubjects": "58"}, {"groupId": "FG002", "numSubjects": "63"}, {"groupId": "FG003", "numSubjects": "62"}, {"groupId": "FG004", "numSubjects": "63"}, {"groupId": "FG005", "numSubjects": "57"}, {"groupId": "FG006", "numSubjects": "63"}, {"groupId": "FG007", "numSubjects": "61"}]}, {"type": "Completed 3rd Period", "achievements": [{"groupId": "FG000", "numSubjects": "48"}, {"groupId": "FG001", "numSubjects": "54"}, {"groupId": "FG002", "numSubjects": "60"}, {"groupId": "FG003", "numSubjects": "61"}, {"groupId": "FG004", "numSubjects": "59"}, {"groupId": "FG005", "numSubjects": "56"}, {"groupId": "FG006", "numSubjects": "59"}, {"groupId": "FG007", "numSubjects": "56"}]}, {"type": "Completed 4th Period", "achievements": [{"groupId": "FG000", "numSubjects": "45"}, {"groupId": "FG001", "numSubjects": "52"}, {"groupId": "FG002", "numSubjects": "55"}, {"groupId": "FG003", "numSubjects": "57"}, {"groupId": "FG004", "numSubjects": "56"}, {"groupId": "FG005", "numSubjects": "49"}, {"groupId": "FG006", "numSubjects": "57"}, {"groupId": "FG007", "numSubjects": "50"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "45"}, {"groupId": "FG001", "numSubjects": "52"}, {"groupId": "FG002", "numSubjects": "55"}, {"groupId": "FG003", "numSubjects": "57"}, {"groupId": "FG004", "numSubjects": "56"}, {"groupId": "FG005", "numSubjects": "49"}, {"groupId": "FG006", "numSubjects": "57"}, {"groupId": "FG007", "numSubjects": "50"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "24"}, {"groupId": "FG001", "numSubjects": "17"}, {"groupId": "FG002", "numSubjects": "16"}, {"groupId": "FG003", "numSubjects": "14"}, {"groupId": "FG004", "numSubjects": "17"}, {"groupId": "FG005", "numSubjects": "23"}, {"groupId": "FG006", "numSubjects": "18"}, {"groupId": "FG007", "numSubjects": "24"}]}], "dropWithdraws": [{"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "5"}, {"groupId": "FG001", "numSubjects": "3"}, {"groupId": "FG002", "numSubjects": "2"}, {"groupId": "FG003", "numSubjects": "4"}, {"groupId": "FG004", "numSubjects": "8"}, {"groupId": "FG005", "numSubjects": "12"}, {"groupId": "FG006", "numSubjects": "6"}, {"groupId": "FG007", "numSubjects": "8"}]}, {"type": "Physician Decision", "reasons": [{"groupId": "FG000", "numSubjects": "2"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "2"}, {"groupId": "FG003", "numSubjects": "1"}, {"groupId": "FG004", "numSubjects": "1"}, {"groupId": "FG005", "numSubjects": "1"}, {"groupId": "FG006", "numSubjects": "1"}, {"groupId": "FG007", "numSubjects": "0"}]}, {"type": "Lack of Efficacy", "reasons": [{"groupId": "FG000", "numSubjects": "2"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "2"}, {"groupId": "FG003", "numSubjects": "2"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "1"}, {"groupId": "FG006", "numSubjects": "0"}, {"groupId": "FG007", "numSubjects": "2"}]}, {"type": "Pregnancy", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}, {"groupId": "FG006", "numSubjects": "1"}, {"groupId": "FG007", "numSubjects": "1"}]}, {"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}, {"groupId": "FG005", "numSubjects": "0"}, {"groupId": "FG006", "numSubjects": "0"}, {"groupId": "FG007", "numSubjects": "1"}]}, {"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "15"}, {"groupId": "FG001", "numSubjects": "14"}, {"groupId": "FG002", "numSubjects": "10"}, {"groupId": "FG003", "numSubjects": "7"}, {"groupId": "FG004", "numSubjects": "8"}, {"groupId": "FG005", "numSubjects": "9"}, {"groupId": "FG006", "numSubjects": "10"}, {"groupId": "FG007", "numSubjects": "12"}]}]}]}, "baselineCharacteristicsModule": {"populationDescription": "All randomized participants", "groups": [{"id": "BG000", "title": "Crossover Sequence 1", "description": "Flovent Diskus\u00ae 250 mcg,followed by Advair Diskus\u00ae 250/50 mcg, followed by Flovent Diskus\u00ae 100 mcg, followed by Advair Diskus\u00ae 100/50 mcg\n\nFlovent Diskus\u00ae 100 mcg: Flovent is an ICS\n\nFlovent Diskus\u00ae 250 mcg: Flovent is an ICS\n\nAdvair Diskus\u00ae 100/50 mcg: Advair is an ICS/LABA combination\n\nAdvair Diskus\u00ae 250/50 mcg: Advair is an ICS/LABA combination"}, {"id": "BG001", "title": "Crossover Sequence 2", "description": "Advair Diskus\u00ae 250/50 mcg, followed by Advair Diskus\u00ae 100/50 mcg, followed by Flovent Diskus\u00ae 250 mcg, followed by Flovent Diskus\u00ae 100 mcg\n\nFlovent Diskus\u00ae 100 mcg: Flovent is an ICS\n\nFlovent Diskus\u00ae 250 mcg: Flovent is an ICS\n\nAdvair Diskus\u00ae 100/50 mcg: Advair is an ICS/LABA combination\n\nAdvair Diskus\u00ae 250/50 mcg: Advair is an ICS/LABA combination"}, {"id": "BG002", "title": "Crossover Sequence 3", "description": "Flovent Diskus\u00ae 100 mcg, followed by Flovent Diskus\u00ae 250 mcg, followed by Advair Diskus\u00ae 100/50 mcg, followed by Advair Diskus\u00ae 250/50 mcg\n\nFlovent Diskus\u00ae 100 mcg: Flovent is an ICS\n\nFlovent Diskus\u00ae 250 mcg: Flovent is an ICS\n\nAdvair Diskus\u00ae 100/50 mcg: Advair is an ICS/LABA combination\n\nAdvair Diskus\u00ae 250/50 mcg: Advair is an ICS/LABA combination"}, {"id": "BG003", "title": "Crossover Sequence 4", "description": "Advair Diskus\u00ae 100/50 mcg, followed by Flovent Diskus\u00ae 100 mcg, followed by Advair Diskus\u00ae 250/50 mcg, followed by Flovent Diskus\u00ae 250 mcg\n\nFlovent Diskus\u00ae 100 mcg: Flovent is an ICS\n\nFlovent Diskus\u00ae 250 mcg: Flovent is an ICS\n\nAdvair Diskus\u00ae 100/50 mcg: Advair is an ICS/LABA combination\n\nAdvair Diskus\u00ae 250/50 mcg: Advair is an ICS/LABA combination"}, {"id": "BG004", "title": "Crossover Sequence 5", "description": "Flovent Diskus\u00ae 500 mcg, followed by Advair Diskus\u00ae 250/50 mcg, followed by Flovent Diskus\u00ae 250 mcg, followed by Advair Diskus\u00ae 100/50 mcg\n\nFlovent Diskus\u00ae 250 mcg: Flovent is an ICS\n\nFlovent Diskus\u00ae 500 mcg: Flovent is an ICS\n\nAdvair Diskus\u00ae 100/50 mcg: Advair is an ICS/LABA combination\n\nAdvair Diskus\u00ae 250/50 mcg: Advair is an ICS/LABA combination"}, {"id": "BG005", "title": "Crossover Sequence 6", "description": "Advair Diskus\u00ae 250/50 mcg, followed by Advair Diskus\u00ae 100/50 mcg, followed by Flovent Diskus\u00ae 500 mcg, followed by Flovent Diskus\u00ae 250 mcg\n\nFlovent Diskus\u00ae 250 mcg: Flovent is an ICS\n\nFlovent Diskus\u00ae 500 mcg: Flovent is an ICS\n\nAdvair Diskus\u00ae 100/50 mcg: Advair is an ICS/LABA combination\n\nAdvair Diskus\u00ae 250/50 mcg: Advair is an ICS/LABA combination"}, {"id": "BG006", "title": "Crossover Sequence 7", "description": "Flovent Diskus\u00ae 250 mcg, followed by Flovent Diskus\u00ae 500 mcg, followed by Advair Diskus\u00ae 100/50 mcg, followed by Advair Diskus\u00ae 250/50 mcg\n\nFlovent Diskus\u00ae 250 mcg: Flovent is an ICS\n\nFlovent Diskus\u00ae 500 mcg: Flovent is an ICS\n\nAdvair Diskus\u00ae 100/50 mcg: Advair is an ICS/LABA combination\n\nAdvair Diskus\u00ae 250/50 mcg: Advair is an ICS/LABA combination"}, {"id": "BG007", "title": "Crossover Sequence 8", "description": "Advair Diskus\u00ae 100/50 mcg, followed by Flovent Diskus\u00ae 250 mcg, followed by Advair Diskus\u00ae 250/50 mcg, followed by Flovent Diskus\u00ae 500 mcg\n\nFlovent Diskus\u00ae 250 mcg: Flovent is an ICS\n\nFlovent Diskus\u00ae 500 mcg: Flovent is an ICS\n\nAdvair Diskus\u00ae 100/50 mcg: Advair is an ICS/LABA combination\n\nAdvair Diskus\u00ae 250/50 mcg: Advair is an ICS/LABA combination"}, {"id": "BG008", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "69"}, {"groupId": "BG001", "value": "69"}, {"groupId": "BG002", "value": "71"}, {"groupId": "BG003", "value": "71"}, {"groupId": "BG004", "value": "73"}, {"groupId": "BG005", "value": "72"}, {"groupId": "BG006", "value": "75"}, {"groupId": "BG007", "value": "74"}, {"groupId": "BG008", "value": "574"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "69"}, {"groupId": "BG001", "value": "69"}, {"groupId": "BG002", "value": "71"}, {"groupId": "BG003", "value": "71"}, {"groupId": "BG004", "value": "73"}, {"groupId": "BG005", "value": "72"}, {"groupId": "BG006", "value": "75"}, {"groupId": "BG007", "value": "74"}, {"groupId": "BG008", "value": "574"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "8.7", "spread": "2.0"}, {"groupId": "BG001", "value": "8.5", "spread": "1.7"}, {"groupId": "BG002", "value": "8.4", "spread": "1.9"}, {"groupId": "BG003", "value": "8.4", "spread": "1.8"}, {"groupId": "BG004", "value": "38.5", "spread": "16.5"}, {"groupId": "BG005", "value": "38.5", "spread": "15.9"}, {"groupId": "BG006", "value": "39.3", "spread": "16.0"}, {"groupId": "BG007", "value": "35.6", "spread": "16.0"}, {"groupId": "BG008", "value": "23.2", "spread": "18.5"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "69"}, {"groupId": "BG001", "value": "69"}, {"groupId": "BG002", "value": "71"}, {"groupId": "BG003", "value": "71"}, {"groupId": "BG004", "value": "73"}, {"groupId": "BG005", "value": "72"}, {"groupId": "BG006", "value": "75"}, {"groupId": "BG007", "value": "74"}, {"groupId": "BG008", "value": "574"}]}], "categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "29"}, {"groupId": "BG001", "value": "27"}, {"groupId": "BG002", "value": "26"}, {"groupId": "BG003", "value": "28"}, {"groupId": "BG004", "value": "52"}, {"groupId": "BG005", "value": "48"}, {"groupId": "BG006", "value": "47"}, {"groupId": "BG007", "value": "52"}, {"groupId": "BG008", "value": "309"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "40"}, {"groupId": "BG001", "value": "42"}, {"groupId": "BG002", "value": "45"}, {"groupId": "BG003", "value": "43"}, {"groupId": "BG004", "value": "21"}, {"groupId": "BG005", "value": "24"}, {"groupId": "BG006", "value": "28"}, {"groupId": "BG007", "value": "22"}, {"groupId": "BG008", "value": "265"}]}]}]}, {"title": "Ethnicity (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "69"}, {"groupId": "BG001", "value": "69"}, {"groupId": "BG002", "value": "71"}, {"groupId": "BG003", "value": "71"}, {"groupId": "BG004", "value": "73"}, {"groupId": "BG005", "value": "72"}, {"groupId": "BG006", "value": "75"}, {"groupId": "BG007", "value": "74"}, {"groupId": "BG008", "value": "574"}]}], "categories": [{"title": "Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "7"}, {"groupId": "BG001", "value": "4"}, {"groupId": "BG002", "value": "7"}, {"groupId": "BG003", "value": "6"}, {"groupId": "BG004", "value": "2"}, {"groupId": "BG005", "value": "2"}, {"groupId": "BG006", "value": "2"}, {"groupId": "BG007", "value": "3"}, {"groupId": "BG008", "value": "33"}]}, {"title": "Not Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "62"}, {"groupId": "BG001", "value": "65"}, {"groupId": "BG002", "value": "64"}, {"groupId": "BG003", "value": "65"}, {"groupId": "BG004", "value": "71"}, {"groupId": "BG005", "value": "70"}, {"groupId": "BG006", "value": "73"}, {"groupId": "BG007", "value": "71"}, {"groupId": "BG008", "value": "541"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}, {"groupId": "BG005", "value": "0"}, {"groupId": "BG006", "value": "0"}, {"groupId": "BG007", "value": "0"}, {"groupId": "BG008", "value": "0"}]}]}]}, {"title": "Race/Ethnicity, Customized", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "Black", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "69"}, {"groupId": "BG001", "value": "69"}, {"groupId": "BG002", "value": "71"}, {"groupId": "BG003", "value": "71"}, {"groupId": "BG004", "value": "73"}, {"groupId": "BG005", "value": "72"}, {"groupId": "BG006", "value": "75"}, {"groupId": "BG007", "value": "74"}, {"groupId": "BG008", "value": "574"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "63"}, {"groupId": "BG001", "value": "65"}, {"groupId": "BG002", "value": "68"}, {"groupId": "BG003", "value": "66"}, {"groupId": "BG004", "value": "69"}, {"groupId": "BG005", "value": "71"}, {"groupId": "BG006", "value": "74"}, {"groupId": "BG007", "value": "73"}, {"groupId": "BG008", "value": "549"}]}]}, {"title": "Other", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "69"}, {"groupId": "BG001", "value": "69"}, {"groupId": "BG002", "value": "71"}, {"groupId": "BG003", "value": "71"}, {"groupId": "BG004", "value": "73"}, {"groupId": "BG005", "value": "72"}, {"groupId": "BG006", "value": "75"}, {"groupId": "BG007", "value": "74"}, {"groupId": "BG008", "value": "574"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "6"}, {"groupId": "BG001", "value": "4"}, {"groupId": "BG002", "value": "3"}, {"groupId": "BG003", "value": "5"}, {"groupId": "BG004", "value": "4"}, {"groupId": "BG005", "value": "1"}, {"groupId": "BG006", "value": "1"}, {"groupId": "BG007", "value": "1"}, {"groupId": "BG008", "value": "25"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "United States", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "69"}, {"groupId": "BG001", "value": "69"}, {"groupId": "BG002", "value": "71"}, {"groupId": "BG003", "value": "71"}, {"groupId": "BG004", "value": "73"}, {"groupId": "BG005", "value": "72"}, {"groupId": "BG006", "value": "75"}, {"groupId": "BG007", "value": "74"}, {"groupId": "BG008", "value": "574"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "69"}, {"groupId": "BG001", "value": "69"}, {"groupId": "BG002", "value": "71"}, {"groupId": "BG003", "value": "71"}, {"groupId": "BG004", "value": "73"}, {"groupId": "BG005", "value": "72"}, {"groupId": "BG006", "value": "75"}, {"groupId": "BG007", "value": "74"}, {"groupId": "BG008", "value": "574"}]}]}]}, {"title": "Forced expiratory volume at one second (FEV1) Percent of Predicted", "description": "FEV1, expressed as percent of predicted FEV1 based on age, sex, race, and height.", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "percent", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "69"}, {"groupId": "BG001", "value": "69"}, {"groupId": "BG002", "value": "71"}, {"groupId": "BG003", "value": "71"}, {"groupId": "BG004", "value": "73"}, {"groupId": "BG005", "value": "72"}, {"groupId": "BG006", "value": "75"}, {"groupId": "BG007", "value": "74"}, {"groupId": "BG008", "value": "574"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "98.1", "spread": "15.4"}, {"groupId": "BG001", "value": "92.6", "spread": "17.9"}, {"groupId": "BG002", "value": "95", "spread": "13.6"}, {"groupId": "BG003", "value": "96.2", "spread": "19.1"}, {"groupId": "BG004", "value": "83.8", "spread": "19.1"}, {"groupId": "BG005", "value": "82.9", "spread": "15.5"}, {"groupId": "BG006", "value": "83.7", "spread": "17.3"}, {"groupId": "BG007", "value": "83.4", "spread": "18"}, {"groupId": "BG008", "value": "89.3", "spread": "18.1"}]}]}]}, {"title": "Asthma Control Test", "description": "Asthma Control Test: The score is calculated as the sum total of a 5-item questionnaire. Each item ranges from 1 (poor control) to 5 (good control) so that the range of the total score is 5 to 25. Scores below 20 indicate that asthma is not well controlled.", "populationDescription": "Asthma Control Test is not validated for use in children", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "units on a scale", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "73"}, {"groupId": "BG005", "value": "72"}, {"groupId": "BG006", "value": "75"}, {"groupId": "BG007", "value": "74"}, {"groupId": "BG008", "value": "294"}]}], "categories": [{"measurements": [{"groupId": "BG004", "value": "18.9", "spread": "3.8"}, {"groupId": "BG005", "value": "18.6", "spread": "3.9"}, {"groupId": "BG006", "value": "19.2", "spread": "3.7"}, {"groupId": "BG007", "value": "18.8", "spread": "3.8"}, {"groupId": "BG008", "value": "18.9", "spread": "3.8"}]}]}]}, {"title": "Childhood Asthma Control Test", "description": "Childhood Asthma Control Test is for children 4-11 years of age: The score is calculated as the sum total of a 7-item questionnaire. Four items ranges from 0 (poor control) to 3 (good control) and three items ranges from 0 (poor control) to 5 (good control) so so that the range of the total score is 0 to 27. Scores below 20 indicate that asthma is not well controlled.", "populationDescription": "Childhood Asthma Control Test is not validated for use in adults", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "units on a scale", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "69"}, {"groupId": "BG001", "value": "69"}, {"groupId": "BG002", "value": "71"}, {"groupId": "BG003", "value": "71"}, {"groupId": "BG004", "value": "0"}, {"groupId": "BG005", "value": "0"}, {"groupId": "BG006", "value": "0"}, {"groupId": "BG007", "value": "0"}, {"groupId": "BG008", "value": "280"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "21.5", "spread": "3.7"}, {"groupId": "BG001", "value": "21.2", "spread": "3.6"}, {"groupId": "BG002", "value": "20.7", "spread": "4.1"}, {"groupId": "BG003", "value": "22.1", "spread": "3.6"}, {"groupId": "BG008", "value": "21.4", "spread": "3.8"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "The Primary Outcome is a Composite Measure That Uses Exacerbations, Asthma Control Days During the Last 12 of 14 Weeks of a Treatment Regimen, and Percent Predicted FEV1 at the End of a Treatment Regimen.", "description": "This composite outcome uses a hierarchical method to ascertain differences in asthma control. For each participant, treatments are first compared to see if they differ in terms of exacerbations. If one treatment results in fewer exacerbations than another, it is deemed the superior treatment and no further comparisons are made. If treatment superiority cannot be assigned by exacerbations, then they are compared by asthma control days (ACDs). If one treatment yields at least 31 annualized ACDs more than another, it is deemed the superior treatment. If treatment superiority still cannot be assigned by ACDs, then they are compared by percent predicted FEV1 at the end of a treatment period. If one treatment yields at least 5% greater FEV1 than another, it is deemed the superior treatment. If treatment superiority cannot be assigned by exacerbations, ACDs or FEV1, then that participant is classified as having no differential response.", "populationDescription": "Not all treatments were used in all participants. Flovent 500 was not used in children and Flovent 100 was not used in adolescents and adults", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "probability", "timeFrame": "The last 12 weeks of each 14-week treatment period", "groups": [{"id": "OG000", "title": "Adolescents and Adults", "description": "All study participant age 12 years or greater"}, {"id": "OG001", "title": "Children", "description": "All study participants under age 12 years"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "294"}, {"groupId": "OG001", "value": "280"}]}], "classes": [{"title": "Advair 100/50 superior to Flovent 250", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "294"}, {"groupId": "OG001", "value": "280"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": ".49"}, {"groupId": "OG001", "value": ".46"}]}]}, {"title": "Advair 100/50 inferior to Flovent 250", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "294"}, {"groupId": "OG001", "value": "280"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": ".28"}, {"groupId": "OG001", "value": ".46"}]}]}, {"title": "Advair 100/50 superior to Flovent 500", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "294"}, {"groupId": "OG001", "value": "0"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": ".53"}]}]}, {"title": "Advair 100/50 inferior to Flovent 500", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "294"}, {"groupId": "OG001", "value": "0"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": ".27"}]}]}, {"title": "Advair 100/50 superior to Advair 250/50", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "294"}, {"groupId": "OG001", "value": "280"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": ".42"}, {"groupId": "OG001", "value": ".47"}]}]}, {"title": "Advair 100/50 inferior to Advair 250/50", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "294"}, {"groupId": "OG001", "value": "280"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": ".36"}, {"groupId": "OG001", "value": ".49"}]}]}, {"title": "Advair 100/50 superior to Flovent 100", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "280"}]}], "categories": [{"measurements": [{"groupId": "OG001", "value": ".53"}]}]}, {"title": "Advair 100/50 inferior to Flovent 100", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "280"}]}], "categories": [{"measurements": [{"groupId": "OG001", "value": ".41"}]}]}, {"title": "Advair 250/50 superior to Flovent 250", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "294"}, {"groupId": "OG001", "value": "280"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": ".46"}, {"groupId": "OG001", "value": ".43"}]}]}, {"title": "Advair 250/50 inferior to Flovent 250", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "294"}, {"groupId": "OG001", "value": "280"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": ".33"}, {"groupId": "OG001", "value": ".47"}]}]}, {"title": "Advair 250/50 superior to Flovent 500", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "294"}, {"groupId": "OG001", "value": "0"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": ".49"}]}]}, {"title": "Advair 250/50 inferior to Flovent 500", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "294"}, {"groupId": "OG001", "value": "0"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": ".31"}]}]}, {"title": "Flovent 500 superior to Flovent 250", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "294"}, {"groupId": "OG001", "value": "0"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": ".35"}]}]}, {"title": "Flovent 500 inferior to Flovent 250", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "294"}, {"groupId": "OG001", "value": "0"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": ".40"}]}]}, {"title": "Flovent 250 superior to Flovent 100", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "280"}]}], "categories": [{"measurements": [{"groupId": "OG001", "value": ".51"}]}]}, {"title": "Flovent 250 inferior to Flovent 100", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "280"}]}], "categories": [{"measurements": [{"groupId": "OG001", "value": ".37"}]}]}], "analyses": [{"groupIds": ["OG000"], "groupDescription": "Test of the null hypothesis that the superiority of Advair 100/50 compared to Fluticasone 250 is equal to the inferiority of Advair 100/50 compared to Fluticasone 250", "nonInferiorityType": "SUPERIORITY", "pValue": "0.003", "statisticalMethod": "Mixed Models Analysis"}, {"groupIds": ["OG001"], "groupDescription": "Test of the null hypothesis that the superiority of Advair 100/50 compared to Fluticasone 250 is equal to the inferiority of Advair 100/50 compared to Fluticasone 250", "nonInferiorityType": "SUPERIORITY", "pValue": "0.9", "statisticalMethod": "Mixed Models Analysis"}, {"groupIds": ["OG000"], "groupDescription": "Test of the null hypothesis that the superiority of Advair 100/50 compared to Fluticasone 500 is equal to the inferiority of Advair 100/50 compared to Fluticasone 500", "nonInferiorityType": "SUPERIORITY", "pValue": "<0.001", "statisticalMethod": "Mixed Models Analysis"}, {"groupIds": ["OG000"], "groupDescription": "Test of the null hypothesis that the superiority of Advair 100/50 compared to Advair 250/50 is equal to the inferiority of Advair 100/50 compared to Advair 250/50", "nonInferiorityType": "SUPERIORITY", "pValue": "0.42", "statisticalMethod": "Mixed Models Analysis"}, {"groupIds": ["OG001"], "groupDescription": "Test of the null hypothesis that the superiority of Advair 100/50 compared to Advair 250/50 is equal to the inferiority of Advair 100/50 compared to Advair 250/50", "nonInferiorityType": "SUPERIORITY", "pValue": "0.84", "statisticalMethod": "Mixed Models Analysis"}, {"groupIds": ["OG000"], "groupDescription": "Test of the null hypothesis that the superiority of Advair 250/50 compared to Fluticasone 500 is equal to the inferiority of Advair 250/50 compared to Fluticasone 500", "nonInferiorityType": "SUPERIORITY", "pValue": "0.015", "statisticalMethod": "Mixed Models Analysis"}, {"groupIds": ["OG000"], "groupDescription": "Test of the null hypothesis that the superiority of Advair 250/50 compared to Fluticasone 250 is equal to the inferiority of Advair 250/50 compared to Fluticasone 250", "nonInferiorityType": "SUPERIORITY", "pValue": "0.085", "statisticalMethod": "Mixed Models Analysis"}, {"groupIds": ["OG001"], "groupDescription": "Test of the null hypothesis that the superiority of Advair 250/50 compared to Fluticasone 250 is equal to the inferiority of Advair 250/50 compared to Fluticasone 250", "nonInferiorityType": "SUPERIORITY", "pValue": "0.62", "statisticalMethod": "Mixed Models Analysis"}, {"groupIds": ["OG000"], "groupDescription": "Test of the null hypothesis that the superiority of Fluticasone 500 compared to Fluticasone 250 is equal to the inferiority of Fluticasone 500 compared to Fluticasone 250", "nonInferiorityType": "SUPERIORITY", "pValue": "0.48", "statisticalMethod": "Mixed Models Analysis"}, {"groupIds": ["OG001"], "groupDescription": "Test of the null hypothesis that the superiority of Advair 100/50 compared to Fluticasone 100 is equal to the inferiority of Advair 100/50 compared to Fluticasone 100", "nonInferiorityType": "SUPERIORITY", "pValue": "0.14", "statisticalMethod": "Mixed Models Analysis"}, {"groupIds": ["OG001"], "groupDescription": "Test of the null hypothesis that the superiority of Fluticasone 250 compared to Fluticasone 100 is equal to the inferiority of Fluticasone 250 compared to Fluticasone 100", "nonInferiorityType": "SUPERIORITY", "pValue": "0.096", "statisticalMethod": "Mixed Models Analysis"}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "timeFrame": "Each participant was followed over the course of four 14-week treatment periods for a total of 56 weeks. The adverse events recorded below are reported at the treatment period level and represent 14 weeks of \"at risk\" exposure time.", "eventGroups": [{"id": "EG000", "title": "Flovent 250 in Pediatric Group", "description": "Flovent 250 in participants under 12 years", "deathsNumAffected": 0, "deathsNumAtRisk": 280, "seriousNumAffected": 8, "seriousNumAtRisk": 280, "otherNumAffected": 64, "otherNumAtRisk": 280}, {"id": "EG001", "title": "Advair 250/50 in Pediatric Group", "description": "Advair 250/50 in participants under 12 years", "deathsNumAffected": 0, "deathsNumAtRisk": 280, "seriousNumAffected": 1, "seriousNumAtRisk": 280, "otherNumAffected": 52, "otherNumAtRisk": 280}, {"id": "EG002", "title": "Flovent 100 in Pediatric Group", "description": "Flovent 100 in participants under 12 years", "deathsNumAffected": 0, "deathsNumAtRisk": 280, "seriousNumAffected": 2, "seriousNumAtRisk": 280, "otherNumAffected": 43, "otherNumAtRisk": 280}, {"id": "EG003", "title": "Advair 100/50 in Pediatric Group", "description": "Advair 100/50 in participants under 12 years", "deathsNumAffected": 0, "deathsNumAtRisk": 280, "seriousNumAffected": 4, "seriousNumAtRisk": 280, "otherNumAffected": 27, "otherNumAtRisk": 280}, {"id": "EG004", "title": "Flovent 500 in Adolescent/Adult Group", "description": "Flovent 500 in participants 12 years and older", "deathsNumAffected": 0, "deathsNumAtRisk": 294, "seriousNumAffected": 10, "seriousNumAtRisk": 294, "otherNumAffected": 53, "otherNumAtRisk": 294}, {"id": "EG005", "title": "Advair 250/50 in Adolescent/Adult Group", "description": "Advair 250/50 in participants 12 years and older", "deathsNumAffected": 0, "deathsNumAtRisk": 294, "seriousNumAffected": 7, "seriousNumAtRisk": 294, "otherNumAffected": 47, "otherNumAtRisk": 294}, {"id": "EG006", "title": "Flovent 250 in Adolescent/Adult Group", "description": "Flovent 250 in participants 12 years and older", "deathsNumAffected": 0, "deathsNumAtRisk": 294, "seriousNumAffected": 7, "seriousNumAtRisk": 294, "otherNumAffected": 35, "otherNumAtRisk": 294}, {"id": "EG007", "title": "Advair 100/50 in Adolescent/Adult Group", "description": "Advair 100/50 in participants 12 years and older", "deathsNumAffected": 0, "deathsNumAtRisk": 294, "seriousNumAffected": 8, "seriousNumAtRisk": 294, "otherNumAffected": 34, "otherNumAtRisk": 294}], "seriousEvents": [{"term": "Anemia", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "ICD-9", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG006", "numEvents": 1, "numAffected": 1, "numAtRisk": 294}, {"groupId": "EG007", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}]}, {"term": "Acute Pericarditis", "organSystem": "Cardiac disorders", "sourceVocabulary": "ICD-9", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG006", "numEvents": 1, "numAffected": 1, "numAtRisk": 294}, {"groupId": "EG007", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}]}, {"term": "Acute Gastritis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "ICD-9", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 294}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG007", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}]}, {"term": "Acute Peptic Ulcer", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "ICD-9", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 294}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG007", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}]}, {"term": "Acute Kidney Failure", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "ICD-9", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 294}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG007", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}]}, {"term": "Lumbar Spinal Cord Compression", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "ICD-9", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 294}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG007", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}]}, {"term": "Acute Post-Op Pain", "organSystem": "Nervous system disorders", "sourceVocabulary": "ICD-9", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG007", "numEvents": 1, "numAffected": 1, "numAtRisk": 294}]}, {"term": "Migraine", "organSystem": "Nervous system disorders", "sourceVocabulary": "ICD-9", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG007", "numEvents": 1, "numAffected": 1, "numAtRisk": 294}]}, {"term": "Asthma Exacerbation", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "ICD-9", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 280}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 280}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 280}, {"groupId": "EG003", "numEvents": 2, "numAffected": 2, "numAtRisk": 280}, {"groupId": "EG004", "numEvents": 4, "numAffected": 4, "numAtRisk": 294}, {"groupId": "EG005", "numEvents": 2, "numAffected": 2, "numAtRisk": 294}, {"groupId": "EG006", "numEvents": 1, "numAffected": 1, "numAtRisk": 294}, {"groupId": "EG007", "numEvents": 3, "numAffected": 3, "numAtRisk": 294}]}, {"term": "Pneumonia", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "ICD-9", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 294}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG006", "numEvents": 2, "numAffected": 2, "numAtRisk": 294}, {"groupId": "EG007", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}]}, {"term": "Flu", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "ICD-9", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 280}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG007", "numEvents": 1, "numAffected": 1, "numAtRisk": 294}]}, {"term": "Adverse Food Reaction", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "ICD-9", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 294}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG007", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}]}, {"term": "Anaphylactic Shock", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "ICD-9", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 294}, {"groupId": "EG006", "numEvents": 1, "numAffected": 1, "numAtRisk": 294}, {"groupId": "EG007", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}]}, {"term": "Closed Fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "ICD-9", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 280}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG007", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}]}, {"term": "Major Depression", "organSystem": "Psychiatric disorders", "sourceVocabulary": "ICD-9", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG006", "numEvents": 1, "numAffected": 1, "numAtRisk": 294}, {"groupId": "EG007", "numEvents": 1, "numAffected": 1, "numAtRisk": 294}]}, {"term": "Drug Withdrawal", "organSystem": "Psychiatric disorders", "sourceVocabulary": "ICD-9", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG007", "numEvents": 1, "numAffected": 1, "numAtRisk": 294}]}, {"term": "Intermittent Explosive Disorder", "organSystem": "Psychiatric disorders", "sourceVocabulary": "ICD-9", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 280}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG007", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}]}, {"term": "Malignant Neoplasm Brain", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "ICD-9", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 294}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG007", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}]}, {"term": "Malignant Neoplasm Thyroid", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "ICD-9", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 294}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG007", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}]}, {"term": "Altered Mental Status", "organSystem": "Psychiatric disorders", "sourceVocabulary": "ICD-9", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 280}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG007", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}]}, {"term": "Chest Pain Not Elsewhere Classified", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "ICD-9", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 294}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG007", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}]}, {"term": "Convulsions Not Elsewhere Classified", "organSystem": "General disorders", "sourceVocabulary": "ICD-9", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 280}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG005", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG007", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}]}, {"term": "Syncope and Collapse", "organSystem": "General disorders", "sourceVocabulary": "ICD-9", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 280}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG005", "numEvents": 1, "numAffected": 1, "numAtRisk": 294}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG007", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}]}], "otherEvents": [{"term": "Acute Nasopharyngitis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "ICD-9", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 35, "numAffected": 20, "numAtRisk": 280}, {"groupId": "EG001", "numEvents": 36, "numAffected": 18, "numAtRisk": 280}, {"groupId": "EG002", "numEvents": 33, "numAffected": 19, "numAtRisk": 280}, {"groupId": "EG003", "numEvents": 39, "numAffected": 20, "numAtRisk": 280}, {"groupId": "EG004", "numEvents": 33, "numAffected": 24, "numAtRisk": 294}, {"groupId": "EG005", "numEvents": 46, "numAffected": 27, "numAtRisk": 294}, {"groupId": "EG006", "numEvents": 40, "numAffected": 20, "numAtRisk": 294}, {"groupId": "EG007", "numEvents": 42, "numAffected": 22, "numAtRisk": 294}]}, {"term": "Acute Upper Respiratory Tract Infection", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "ICD-9", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 25, "numAffected": 16, "numAtRisk": 280}, {"groupId": "EG001", "numEvents": 14, "numAffected": 10, "numAtRisk": 280}, {"groupId": "EG002", "numEvents": 16, "numAffected": 11, "numAtRisk": 280}, {"groupId": "EG003", "numEvents": 20, "numAffected": 11, "numAtRisk": 280}, {"groupId": "EG004", "numEvents": 19, "numAffected": 11, "numAtRisk": 294}, {"groupId": "EG005", "numEvents": 15, "numAffected": 11, "numAtRisk": 294}, {"groupId": "EG006", "numEvents": 24, "numAffected": 16, "numAtRisk": 294}, {"groupId": "EG007", "numEvents": 20, "numAffected": 13, "numAtRisk": 294}]}, {"term": "Asthma Exacerbation", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "ICD-9", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 41, "numAffected": 23, "numAtRisk": 280}, {"groupId": "EG001", "numEvents": 47, "numAffected": 20, "numAtRisk": 280}, {"groupId": "EG002", "numEvents": 54, "numAffected": 40, "numAtRisk": 280}, {"groupId": "EG003", "numEvents": 31, "numAffected": 18, "numAtRisk": 280}, {"groupId": "EG004", "numEvents": 20, "numAffected": 18, "numAtRisk": 294}, {"groupId": "EG005", "numEvents": 20, "numAffected": 17, "numAtRisk": 294}, {"groupId": "EG006", "numEvents": 22, "numAffected": 17, "numAtRisk": 294}, {"groupId": "EG007", "numEvents": 23, "numAffected": 18, "numAtRisk": 294}]}, {"term": "Cough", "organSystem": "General disorders", "sourceVocabulary": "ICD-9", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 20, "numAffected": 11, "numAtRisk": 280}, {"groupId": "EG001", "numEvents": 23, "numAffected": 10, "numAtRisk": 280}, {"groupId": "EG002", "numEvents": 24, "numAffected": 13, "numAtRisk": 280}, {"groupId": "EG003", "numEvents": 21, "numAffected": 15, "numAtRisk": 280}, {"groupId": "EG004", "numEvents": 2, "numAffected": 2, "numAtRisk": 294}, {"groupId": "EG005", "numEvents": 5, "numAffected": 3, "numAtRisk": 294}, {"groupId": "EG006", "numEvents": 7, "numAffected": 6, "numAtRisk": 294}, {"groupId": "EG007", "numEvents": 3, "numAffected": 3, "numAtRisk": 294}]}, {"term": "Fever", "organSystem": "General disorders", "sourceVocabulary": "ICD-9", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 11, "numAffected": 10, "numAtRisk": 280}, {"groupId": "EG001", "numEvents": 8, "numAffected": 6, "numAtRisk": 280}, {"groupId": "EG002", "numEvents": 19, "numAffected": 16, "numAtRisk": 280}, {"groupId": "EG003", "numEvents": 10, "numAffected": 8, "numAtRisk": 280}, {"groupId": "EG004", "numEvents": 4, "numAffected": 4, "numAtRisk": 294}, {"groupId": "EG005", "numEvents": 3, "numAffected": 3, "numAtRisk": 294}, {"groupId": "EG006", "numEvents": 0, "numAffected": 0, "numAtRisk": 294}, {"groupId": "EG007", "numEvents": 5, "numAffected": 4, "numAtRisk": 294}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "David Mauger", "organization": "Penn State University", "email": "dmauger@psu.edu", "phone": "717-531-7178"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot_SAP", "hasProtocol": true, "hasSap": true, "hasIcf": false, "label": "Study Protocol and Statistical Analysis Plan", "date": "2017-07-21", "uploadDate": "2018-08-31T09:48", "filename": "Prot_SAP_000.pdf", "size": 1960840}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000068298", "term": "Fluticasone"}, {"id": "C000716389", "term": "Xhance"}, {"id": "D000068297", "term": "Fluticasone-Salmeterol Drug Combination"}], "ancestors": [{"id": "D000001993", "term": "Bronchodilator Agents"}, {"id": "D000001337", "term": "Autonomic Agents"}, {"id": "D000018373", "term": "Peripheral Nervous System Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000018927", "term": "Anti-Asthmatic Agents"}, {"id": "D000019141", "term": "Respiratory System Agents"}, {"id": "D000005938", "term": "Glucocorticoids"}, {"id": "D000006728", "term": "Hormones"}, {"id": "D000006730", "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"id": "D000013566", "term": "Sympathomimetics"}, {"id": "D000000893", "term": "Anti-Inflammatory Agents"}, {"id": "D000003879", "term": "Dermatologic Agents"}, {"id": "D000018926", "term": "Anti-Allergic Agents"}], "browseLeaves": [{"id": "M250", "name": "Fluticasone", "asFound": "Desensitization", "relevance": "HIGH"}, {"id": "M353494", "name": "Xhance", "asFound": "Myocardium", "relevance": "HIGH"}, {"id": "M251", "name": "Salmeterol Xinafoate", "relevance": "LOW"}, {"id": "M249", "name": "Fluticasone-Salmeterol Drug Combination", "asFound": "Fabry Disease", "relevance": "HIGH"}, {"id": "M5269", "name": "Bronchodilator Agents", "relevance": "LOW"}, {"id": "M20963", "name": "Anti-Asthmatic Agents", "relevance": "LOW"}, {"id": "M21137", "name": "Respiratory System Agents", "relevance": "LOW"}, {"id": "M9047", "name": "Glucocorticoids", "relevance": "LOW"}, {"id": "M9789", "name": "Hormones", "relevance": "LOW"}, {"id": "M9788", "name": "Hormone Antagonists", "relevance": "LOW"}, {"id": "M16345", "name": "Sympathomimetics", "relevance": "LOW"}, {"id": "M4217", "name": "Anti-Inflammatory Agents", "relevance": "LOW"}, {"id": "M7074", "name": "Dermatologic Agents", "relevance": "LOW"}, {"id": "M20962", "name": "Anti-Allergic Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "AAll", "name": "Anti-Allergic Agents"}, {"abbrev": "Infl", "name": "Anti-Inflammatory Agents"}, {"abbrev": "Derm", "name": "Dermatologic Agents"}, {"abbrev": "Resp", "name": "Respiratory System Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}